3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Thyroid Diseases
1
Parathyroid Diseases
1
Neurilemmoma
1
Neoplasms
1
Meningioma
1
Lung Neoplasms
1
Low Grade Glioma of Brain
1
Liver Neoplasms
1
Inflammatory Bowel Diseases
1
Inflammation
1
Glioma
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Brain Neoplasms
1
Interventions
Sorafenib
42
Bevacizumab
26
Oxaliplatin
21
Radiosurgery
19
Gemcitabine
17
Fluorouracil
15
Hepatectomy
13
lenvatinib
12
Radiofrequency Ablation
11
Nivolumab
11
Cisplatin
11
Radiotherapy
10
Doxorubicin
10
Capecitabine
10
durvalumab
9
Leucovorin
9
Blood Specimen Collection
9
atezolizumab
8
Liver Transplantation
8
Everolimus
7
Electroporation
7
pembrolizumab
6
camrelizumab
6
Sunitinib
6
Immunohistochemistry
6
Cryosurgery
6
Carboplatin
6
tremelimumab
5
sintilimab
5
apatinib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Liver Neoplasms
×
Hyperspectral Imaging
×
Clear all
NCT04589884
2024-01-09
iEXMachyna3
IHU Strasbourg
Terminated
112 enrolled